Search research articles
Contact Us
Filters
Showing results (131-140 of 539) with videos related to
Page
of 54
Sort By:
Journal of Neurosurgery
|
August 10, 2000
Excitotoxic ablation
J Guridi, E Ramos, G Linazasoro, et al.
Trends in Neurosciences
|
October 29, 2000
Levodopa motor complications in Parkinson's disease
J A Obeso, C W Olanow, J G Nutt
Neurology
|
January 9, 2001
The place of COMT inhibitors in the armamentarium of drugs for the treatment of Parkinson's disease
A H Schapira, J A Obeso, C W Olanow
Journal of Neurology, Neurosurgery, and Psychiatry
|
May 1, 1995
Hemiballism in Parkinson's disease
J A Obeso, J Guridi, G Linazasoro, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
January 1, 1984
On the significance of giant somatosensory evoked potentials in cortical myoclonus
J C Rothwell, J A Obeso, C D Marsden
Nature Reviews. Neuroscience
|
January 21, 2017
Selective neuronal vulnerability in Parkinson disease
D James Surmeier, José A Obeso, Glenda M Halliday
Revista Clinica Espanola
|
April 30, 1979
[Diabetic neuropathy: etiology, diagnosis and evolution]
J A Obeso, J F Marti Masso, N Carrera
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
October 13, 2017
Parkinson's Disease Is Not Simply a Prion Disorder
D James Surmeier, José A Obeso, Glenda M Halliday
Neurology
|
February 1, 1993
Time course of postanoxic akinetic-rigid and dystonic syndromes
M H Bhatt, J A Obeso, C D Marsden
Journal of Neuroscience Research
|
September 3, 2013
Ascorbate prevents cell death from prolonged exposure to glutamate in an in vitro model of human dopaminergic neurons
Santiago Ballaz, Ingrid Morales, Manuel Rodríguez, et al.
Page
of 54
Search research articles
Search
Showing results (131-140 of 539) with videos related to
Sort By:
Page
of 54
Journal of Neurosurgery
|
August 10, 2000
Excitotoxic ablation
J Guridi, E Ramos, G Linazasoro, et al.
Trends in Neurosciences
|
October 29, 2000
Levodopa motor complications in Parkinson's disease
J A Obeso, C W Olanow, J G Nutt
Neurology
|
January 9, 2001
The place of COMT inhibitors in the armamentarium of drugs for the treatment of Parkinson's disease
A H Schapira, J A Obeso, C W Olanow
Journal of Neurology, Neurosurgery, and Psychiatry
|
May 1, 1995
Hemiballism in Parkinson's disease
J A Obeso, J Guridi, G Linazasoro, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
January 1, 1984
On the significance of giant somatosensory evoked potentials in cortical myoclonus
J C Rothwell, J A Obeso, C D Marsden
Nature Reviews. Neuroscience
|
January 21, 2017
Selective neuronal vulnerability in Parkinson disease
D James Surmeier, José A Obeso, Glenda M Halliday
Revista Clinica Espanola
|
April 30, 1979
[Diabetic neuropathy: etiology, diagnosis and evolution]
J A Obeso, J F Marti Masso, N Carrera
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
October 13, 2017
Parkinson's Disease Is Not Simply a Prion Disorder
D James Surmeier, José A Obeso, Glenda M Halliday
Neurology
|
February 1, 1993
Time course of postanoxic akinetic-rigid and dystonic syndromes
M H Bhatt, J A Obeso, C D Marsden
Journal of Neuroscience Research
|
September 3, 2013
Ascorbate prevents cell death from prolonged exposure to glutamate in an in vitro model of human dopaminergic neurons
Santiago Ballaz, Ingrid Morales, Manuel Rodríguez, et al.
Page
of 54